Position in CYTK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$580,314
+$315,356 QoQ
Shares Held
6,812
+69.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#295
of 477 holders
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVERGREEN CAPITAL MANAGEMENT LLC holds $27,458,740 across 28 Biotechnology names. CYTK ranks #13 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,761 | $11,074,693 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,222 | $2,097,194 | |
| 3 | ARGX |
Argenx SE
|
1,836 | $1,703,385 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
22,421 | $1,282,929 | |
| 5 | NUVL |
Nuvalent, Inc.
|
8,952 | $1,105,572 | |
| 6 | EXEL |
Exelixis, Inc.
|
15,411 | $838,512 | |
| 7 | RPRX |
Royalty Pharma plc
|
14,344 | $804,267 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
9,014 | $783,767 |
All Filings in CYTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $580,314 | 6,812 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $264,958 | 4,020 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $216,099 | 3,401 | Shares | Other | 2026-01-27 | |
| 2024-03-31 | $291,867 | 4,163 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $284,283 | 3,405 | Shares | Other | 2024-02-14 | |
| 2022-09-30 | $204,313 | 4,217 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||